Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.

MLA

Togt, C. J. T.van der, et al. “Points to Consider for Cost-Effective Use of Biological and Targeted Synthetic DMARDs in Inflammatory Rheumatic Diseases: Results from an Umbrella Review and International Delphi Study.” Rheumatic & Musculoskeletal Diseases Open, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1374574904&authtype=sso&custid=ns315887.

APA

Togt, C. J. T. van der, Bemt, B. J. van den, Aletaha, D., Alten, R., Chatzidionysiou, K., Galloway, J., Isaac, J., Mulleman, D., Verschueren, P., Vulto, A. G., Welsing, P. M. J., Verhoef, L., & Broeder, A. A. den. (2023). Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. Rheumatic & Musculoskeletal Diseases Open.

Chicago

Togt, C.J.T. van der, B.J. van den Bemt, D. Aletaha, R. Alten, K. Chatzidionysiou, J. Galloway, J. Isaac, et al. 2023. “Points to Consider for Cost-Effective Use of Biological and Targeted Synthetic DMARDs in Inflammatory Rheumatic Diseases: Results from an Umbrella Review and International Delphi Study.” Rheumatic & Musculoskeletal Diseases Open. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1374574904&authtype=sso&custid=ns315887.